Literature DB >> 21190270

Liver volume in trisomy 21 and euploid fetuses at 11 to 13 weeks.

Yuval Gielchinsky1, Mona Zvanca, Ryoko Minekawa, Nicola Persico, Kypros H Nicolaides.   

Abstract

OBJECTIVES: To compare liver volume between trisomy 21 and euploid fetuses at 11 to 13 weeks' gestation.
METHODS: Fetal liver volume was measured by 3D ultrasound in fetuses at low risk of aneuploidies (n = 200) and another group at high risk, including 148 euploid and 37 with trisomy 21. The association of liver volume with fetal nuchal translucency (NT) thickness, tricuspid regurgitation and reversed a-wave in the ductus venosus was investigated.
RESULTS: In the low-risk group, fetal liver volume increased exponentially with fetal crown-rump length (CRL) from a median of 0.5 cm(3) at CRL of 45 mm to about 2.5 cm(3) at CRL of 84 mm. In 27 (73.0%) of the trisomy 21 fetuses liver volume was above the 95th percentile of the low-risk group, whereas in the euploid fetuses liver volume was not significantly altered (P = 0.521). There were no significant contributions to liver volume from fetal NT (P = 0.508), tricuspid regurgitation (P = 0.958) or reversed a-wave in the ductus venosus (P = 0.872).
CONCLUSION: In trisomy 21 fetuses at 11 to 13 weeks liver volume is increased.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21190270     DOI: 10.1002/pd.2633

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Scaling in vitro activity of CYP3A7 suggests human fetal livers do not clear retinoic acid entering from maternal circulation.

Authors:  Ariel R Topletz; Guo Zhong; Nina Isoherranen
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

2.  Volumetric Growth of the Liver in the Human Fetus: An Anatomical, Hydrostatic, and Statistical Study.

Authors:  Michał Szpinda; Monika Paruszewska-Achtel; Alina Woźniak; Celestyna Mila-Kierzenkowska; Gabriela Elminowska-Wenda; Małgorzata Dombek; Anna Szpinda; Mateusz Badura
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.